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Background: The usage of nursing home (NH) services is a marker of frailty among older adults. Although the
Centers for Medicare & Medicaid Services (CMS) revised the Medical Evidence Report Form CMS-2728 in 2005 to
include data collection on NH institutionalization, the validity of this item has not been reported.
Methods: There were 27,913 patients ≥ 75 years of age with incident end-stage renal disease (ESRD) in 2006,
which constituted our analysis cohort. We determined the accuracy of the CMS-2728 using a matched cohort that
included the CMS Minimum Data Set (MDS) 2.0, often employed as a “gold standard” metric for identifying patients
receiving NH care. We calculated sensitivity, specificity, positive predictive value (PPV), and negative predictive value
(NPV) for the CMS-2728 NH item. Next, we compared characteristics and mortality risk by CMS-2728 and MDS NH
status agreement.
Results: The sensitivity, specificity, PPV and NPV of the CMS-2728 for NH status were 33%, 97%, 80% and 79%,
respectively. Compared to those without the MDS or CMS-2728 NH indicator (No MDS/No 2728), multivariable
adjusted hazard ratios (95% confidence interval) for mortality associated with NH status were 1.55 (1.46 – 1.64) for
MDS/2728, 1.48 (1.42 – 1.54) for MDS/No 2728, and 1.38 (1.25 – 1.52) for No MDS/2728. NH utilization was more
strongly associated with mortality than other CMS-2728 items in the model.
Conclusions: The CMS-2728 underestimated NH utilization among older adults with incident ESRD. The potential
for misclassification may have important ramifications for assessing prognosis, developing advanced care plans and
providing coordinated care.
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Older adults are the fastest growing group initiating dialysis
in the United States [1,2]. In 2011, for persons 75 years and
older the adjusted incidence rate of end-stage renal disease
(ESRD) was 1,707 per million population, up 7.1% from
2000 [1]. For older adults, progression to ESRD carries a
poor prognosis and increased risk for hospitalization and
death [3-5]. Although frailty and functional impairment* Correspondence: cbbowli@emory.edu
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unless otherwise stated.have been shown to be common and associated with poor
health outcomes in ESRD, these measures are not com-
monly captured in the routine care of these patients [4,6,7].
The usage of nursing home (NH) services is a marker of
frailty among older adults [8]. Prior studies have shown
that dialysis initiation may precede loss of independence
and need for nursing home placement [3]. Additionally,
among long-term NH residents dialysis initiation was
shown to be associated with persistent functional decline
and reduced survival [5]. However, data on NH care
among incident ESRD patients is limited [9,10]. Failing to
recognize NH utilization as a significant risk factor for
mortality may impact prognostication and clinical decision
making for older patients with advanced kidney disease.l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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(CMS) Medical Evidence Report (Form CMS-2728) was
revised to include data collection on whether or not the
patient is institutionalized in a NH. While this new data
collection provides the opportunity to describe the
utilization and outcomes associated with institutional
care, the validity of the CMS-2728 to identify NH pa-
tients has not been reported. Therefore, the aims of the
current analysis were to report the accuracy of the
CMS-2728 NH item among incident ESRD patients ≥
75 years old using a matched cohort that included the
CMS Long Term Care Minimum Data Set (MDS), a
“gold standard” metric for identifying patients receiving
NH care. In order to assess potential implications for
failing to recognize or report NH utilization, we com-
pared mortality risk by CMS-2728 and MDS NH status
agreement.
Methods
Data sources and participants
Data were obtained through the United States Renal
Data System (USRDS). The current analysis was limited
to 27,913 patients ≥ 75 years old with incident ESRD and
completion of the CMS-2728 during 2006. We chose
this age cut point because of the increase in proportion
of US adults requiring nursing home services after the
age of 75 years compared to ≤ 74 years of age [11]. Data
on other covariates were obtained through the CMS-
2728 and includes the demographic factors of age, gen-
der, race, ethnicity, Medicaid coverage, region of resi-
dence (defined by US Census Regions Northeast, South,
Midwest and West). Treating physicians are required to
complete the CMS-2728 form within 45 days of the first
maintenance renal replacement therapy for all ESRD pa-
tients regardless of current or future intention to use
Medicare [12]. Health characteristics included primary
cause of renal failure, cardiovascular disease (CVD) co-
morbidity, functional impairment (inability to ambulate,
inability to transfer or assistance needed with activities
of daily living), and laboratory values included serum al-
bumin, serum creatinine and hemoglobin. Treatment
characteristics included primary dialysis setting, primary
type of dialysis, receipt of predialysis nephrology care
and initial type of hemodialysis vascular access. Item
17u is included in the section to be completed by the at-
tending physician and asks if the patient is “Institutional-
ized.” Patients that are institutionalized are further
characterized as “1. Assisted living,” “2. Nursing Home,” or
“3. Other Institution.” To allow for a complete year of data
collection with the newly introduced institutionalization
item on the CMS-2728, our analysis was limited to 2006.
This study protocol was approved by the Emory University
Institutional Review Board. Written informed consent was
not obtained.Nursing home status agreement
In order to determine the accuracy of the CMS-2728 we
used a matched cohort that included the CMS Long
Term Care MDS 2.0 for 2006 obtained from the USRDS
[13]. The MDS is a standardized, primary screening and
assessment tool of health status for all residents admit-
ted to a Medicare or Medicaid certified which includes
95% of all US NHs [14]. CMS collects MDS data
through surveys that are administered on admission,
quarterly, annually, or after a significant change in status
(e.g., discharge from NH). Patients with MDS data were
matched with the USRDS database by USRDS ID.
For our primary analysis, patients were defined as re-
ceiving NH care by the MDS 1) if the last MDS record
prior to the ESRD date indicated that they were in a NH
or 2) if they had an MDS record indicating admission to a
NH within 30 days after the ESRD date. Prior studies have
shown delays in completion of the CMS-2728, [15] there-
fore we chose a window of 30 days after the ESRD date in
order to capture those most likely to be receiving NH care
at time of or immediately following dialysis initiation. A
30 day window was chosen based on the Medicare post-
acute care benefit that allows for skilled nursing care in a
nursing home following an acute hospitalization. In sec-
ondary analyses, three additional definitions were consid-
ered including 1) an MDS record prior to the ESRD date
without the 30 day window following the ESRD date, 2)
using the CMS-2728 physician signature date instead of
the ESRD date, and 3) using any institutionalization on
CMS-2728 item 17u (“1. Assisted living,” “2. Nursing
Home,” or “3. Other Institution”).
Mortality
Mortality subsequent to the ESRD date was determined
using data from the USRDS that includes the CMS ESRD
Death Notification (CMS-2746) and social security death
index. A death notification is required when ESRD pa-
tients die, regardless of payer status [12]. Follow-up for
the current analysis was available through 2012.
Statistical analyses
We examined the cross tabulations of NH status ascer-
tained by MDS and by the CMS-2728 and calculated the
sensitivity, specificity, positive predictive value (PPV), and
negative predictive value (NPV) for the CMS-2728 item
17u. Additionally, we calculated the mean length of NH
stay in days from the MDS for those identified by both
MDS and the CMS-2728 versus those identified only by
MDS during the window of 100 days before and 130 days
after the ESRD date. This time window was chosen to cap-
ture ESRD patients requiring NH stays that exceed the
100 days of skilled nursing facility care that is covered by
Medicare Part A after a qualifying hospital stay. Demo-
graphic, health and treatment characteristics were
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as appropriate by 2728 and MDS NH status agreement
category (i.e., MDS/2728, MDS/No 2728, No MDS/2728,
No MDS/No 2728). To assess for patient characteristics
associated with having the CMS-2728 indicator among
those identified as receiving NH care by MDS (i.e., sensi-
tivity), we calculated crude and multivariable adjusted
odds ratios of demographic, health and treatment charac-
teristics with the CMS-2728 NH status using logistic
regression limited to participants in a NH by the MDS.
Next we calculated crude and multivariable adjusted odds
ratios of demographic, health and treatment characteris-
tics associated with not having the CMS-2728 NH indica-
tor limited to participants without an MDS record (i.e.,
specificity). Multivariable adjustment included age, sex,
ethnicity, race, Medicaid use, region of residence, cause of
renal failure, CVD comorbidity, functional impairment,
serum albumin, serum creatinine, hemoglobin, primary
dialysis setting, predialysis nephrology care, initial type
of hemodialysis vascular access and incident ESRD year.
Patients were categorized as having functional impairment
if they had at least one of the following: inability to ambu-
late, inability to transfer or needs assistance with daily
activities. Finally, using the Kaplan-Meier method we
estimated the cumulative mortality by CMS-2728 and
MDS NH status agreement category. Associations of NH
status defined by 1) MDS alone, 2) CMS-2728 alone and
3) MDS/2728 agreement (MDS/2728, MDS/No 2728,
No MDS/2728, No MDS/No 2728) with all-cause mortal-
ity were examined by calculating mortality rates and haz-
ard ratios using three separate Cox proportional hazards
models. For the model with NH status agreement categor-
ies, those with No MDS/No 2728 served as the referent
group. Multivariable adjustment included all demographic,
health and treatment factors described above. SAS, version
9.2 (SAS Institute, Cary NC) was used for all analyses.
Results
Nursing home status reporting on the CMS-2728
Of the 7,801 (27.9%) dialysis patients for whom the MDS
indicated that they were in a NH prior to or 30 days after
the ESRD date, 2,565 (33%) were identified by the CMS-Table 1 Accuracy of the Centers for Medicare & Medicaid Servi
home status versus the “gold standard” CMS nursing home Mi
75 years (n = 27,913)
MDS (n) Sensitivit
CMS-2728 (n) Yes No
Yes 2,565 656 0.33
No 5,236 19,456 (0.32, 0.34)
PPV = positive predictive value.
NPV = negative predictive value.
Nursing home status for the CMS-2728 defined as “2. nursing home” on item 17u.
Nursing home status for the MDS was defined by an MDS record prior to the ESRD
indicating admission to a nursing home within 30 days after the ESRD date.2728. In contrast, of the 20,112 participants without MDS
records for NH care, 19,456 (97%) were not in a NH ac-
cording to the CMS-2728. The PPV and NPV of the
CMS-2728 for NH status were 80% and 79%, respectively
(Table 1). Among those for whom the MDS indicated that
they were in a NH, the mean (standard deviation) number
of NH days was 72.5 (56.0) for those identified by CMS-
2728 versus 48.3 (47.3) among those not identified as
receiving NH care (p <0.001). The accuracy of the CMS-
2728 NH item when different definitions were considered
is displayed in Additional file 1 Table S1.
ESRD patient characteristics and nursing home status
Demographic, health and treatment characteristics for
ESRD patients ≥ 75 years old by CMS-2728 and MDS
NH status agreement category are displayed in Table 2.
Overall, patients were similar in age by NH status cat-
egory. Among patients for whom the MDS indicated
that they were in a NH, those with the CMS-2728 NH
indicator were more likely to be women, to be black,
have Medicaid coverage and live in the South or Mid-
west compared to the Northeast or West. Additionally,
within this group, those with the CMS-2728 NH indica-
tor were much more likely to have an inability to ambu-
late (41.4% versus 8.0%), inability to transfer (25.3%
versus 3.3%) or need assistance with daily activities
(56.3% versus 11.7%). However, those without MDS data,
but with the CMS-2728 NH indicator (i.e., No MDS/
2728) had the highest reported prevalence of functional
impairment on the CMS-2728.
Among the 7,801 incident ESRD patients ≥ 75 years old
identified by the MDS as receiving NH care, having Me-
dicaid coverage, residing in the South or Midwest, and
having diabetes as the primary cause of ESRD, were asso-
ciated with a higher odds of being correctly identified as
receiving NH care on the CMS-2728 (Table 3). The multi-
variable adjusted odds ratio (95% confidence interval [CI])
for the association of functional impairment with the
CMS-2728 NH indicator was 10.42 (9.10 – 11.93). Charac-
teristics associated with not having a CMS-2728 NH indi-
cator among those without an MDS record (i.e., modeling
specificity), included Hispanic ethnicity, serum albumin,ces (CMS) Medical Evidence Report Form CMS-2728 nursing
nimum Data Set (MDS) among incident dialysis patients≥
y Specificity PPV NPV
0.97 0.80 0.79
(0.96, 0.97) (0.78, 0.81) (0.78, 0.79)
date indicating that the patient was in a nursing home or an MDS record
Table 2 Demographic, health and treatment characteristics of incident dialysis patients ≥ 75 years old by CMS-2728
and MDS nursing home status agreement (n = 27,913)
MDS (n = 7,801) No MDS (n = 20,112)
2728 No 2728 2728 No 2728
(n = 2,565) (n = 5,236) (n = 656) (n = 19,456)
Demographic characteristics
Age, mean (SD) 81.7 (4.7) 81.6 (4.6) 81.0 (4.5) 80.5 (4.3)
Women, (%) 55.3 51.1 50.3 43.3
Hispanic or Latino 5.8 5.7 7.0 9.7
Race
White 76.8 81.4 77.0 78.5
Black 20.8 15.3 19.5 16.9
American Indian/Alaskan 0.1 0.4 0.3 0.4
Asian 1.8 2.4 2.9 3.3
Other 0.5 0.5 0.3 0.9
Medicaid 28.8 17.5 23.8 15.1
Region of residence
Northeast 21.9 28.7 24.2 20.2
South 35.2 28.6 35.7 36.3
Midwest 31.4 25.0 25.9 22.9
West 11.6 17.6 14.3 20.6
Health characteristics
Primary cause of renal failure
Diabetes 39.2 36.0 39.5 34.4
Glomerular nephritis 3.0 3.8 2.1 4.7
Secondary glomerulonephritis /vasculitis 0.7 1.0 0.9 0.9
Interstitial nephritis 3.9 3.0 2.6 3.7
Hypertension/large vessel 37.3 40.2 35.8 42.1
Cystic/hereditary/congenital 0.4 0.5 0.5 1.5
Neoplasms/tumors 1.8 2.2 1.7 3.0
Other 13.8 13.4 16.9 9.6
CVD Comorbidity
Congestive heart failure 53.3 52.4 54.1 41.9
Atherosclerotic heart disease 32.6 35.0 35.4 32.7
Cerebrovascular disease 19.7 14.4 21.7 11.0
Peripheral vascular disease 21.1 20.2 27.3 18.3
Other 30.0 23.2 35.2 21.3
Functional impairment
Inability to ambulate 41.4 8.0 51.5 5.2
Inability to transfer 25.3 3.3 34.2 2.2
Needs assistance with daily activities 56.3 11.7 58.8 11.3
Serum albumin, g/dL, mean (SD) 2.9 (0.6) 3.0 (0.6) 2.8 (0.7) 3.3 (0.7)
Serum creatinine, mg/dL, mean (SD) 5.1 (2.3) 5.2 (2.4) 5.0 (2.3) 5.5 (2.4)
Hemoglobin, g/dL, mean (SD) 10.2 (1.6) 10.2 (1.6) 10.1 (1.6) 10.4 (1.6)
Treatment characteristics
Primary dialysis setting
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Table 2 Demographic, health and treatment characteristics of incident dialysis patients ≥ 75 years old by CMS-2728
and MDS nursing home status agreement (n = 27,913) (Continued)
Home 1.6 0.8 1.5 4.8
Dialysis facility/Center 94.1 98.0 92.5 95.1
Skilled nursing facility/Long term care facility 4.3 1.2 6.0 0.1
Primary type of dialysis
Hemodialysis 99.1 99.4 99.4 95.4
CAPD 0.7 0.4 0.2 3.1
CCPD 0.2 0.2 0.5 1.5
Other 0.0 0.0 0.0 0.0
Predialysis nephrology care 41.4 45.4 34.6 64.7
Initial type of hemodialysis access
AVF 4.2 5.1 3.5 16.0
Graft 3.3 2.7 3.1 5.3
Catheter 91.4 90.7 91.9 77.4
Other 1.2 1.6 1.5 1.3
CVD = cardiovascular disease
All numbers are percentage or mean (SD).
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vascular disease, peripheral vascular disease, functional
impairment and having an arteriovenous fistula were asso-
ciated with a lower odds of being correctly identified as
not receiving NH care.
Nursing home status and mortality
Overall, there were 24,642 (88%) deaths over a median
426 days of follow-up. Mortality rates per 1,000 person
years were 802, 656, 770 and 357 by NH status agreement
categories MDS/2728, MDS/No 2728, No MDS/2728, No
MDS/No 2728, respectively. Patients identified by either
the MDS or CMS-2728 had a greater risk for death over
follow-up compared to those who were not identified has
receiving NH care by the MDS or CMS-2728 (Figure 1).
Compared to those without the MDS or CMS-2728 NH
indicator (No MDS/No 2728), multivariable adjusted haz-
ard ratios (95% CI) for mortality associated with NH status
were 1.55 (1.46–1.64) for MDS/2728, 1.48 (1.42–1.54) for
MDS/No 2728, and 1.38 (1.25 – 1.52) for No MDS/2728
(Table 4). When modelled separately, both NH status de-
fined by MDS alone or CMS-2728 alone were independ-
ently associated with mortality (top panel Table 4).
Discussion
For incident ESRD patients ≥ 75 years old, the CMS-
2728 may underestimate the true utilization of NH care
in this population, however those identified by the
CMS-2728 as being in a NH have a high probability of
actually being in a NH (i.e., high PPV). When analyses
were repeated with different definitions for NH status,
the sensitivity remained low. Additionally, we found that
NH utilization defined by either the MDS or CMS-2728was associated with mortality. Because other markers of
frailty may not be routinely collected in this population,
inaccurate reporting on the CMS-2728 NH item may
mask important clinical information about older adults
with incident ESRD. Our findings suggest a gap in rec-
ognition of NH care that may have important implica-
tions for assessing prognosis, advanced care planning
and providing coordinated care.
Consistent with prior studies, we found that incident
ESRD carries a poor prognosis for older adults [4,5].
Overall, 88% of incident ESRD patients ≥ 75 years old
died during follow-up. Compared to those with neither
the MDS or CMS-2728 NH indicator (No MDS/No
2728), presence of either NH indicator was associated
with increased mortality. For patients identified by either
the MDS or CMS-2728 as receiving NH care, the first
6 months was a high risk time with 47-50% of all deaths
for these groups occurring during this time period. In
contrast, among those not identified as receiving NH
care by either the MDS or CMS-2728 (n = 19,456), only
24% of the total deaths for this group occurred in the
first 6 months. Similar mortality risk between the MDS/
2728 and MDS/No 2728 groups suggests that relying on
the Medical Evidence Report form alone leads to mis-
classification of a large proportion of older incident
ESRD patients who have a poor prognosis. Reinforcing
the need for accurate reporting of NH status are prior
studies showing that comorbidities alone may not be as
helpful for risk prediction in older adults. For example,
Cheung and colleagues recently reported the poor per-
formance of prognostic indices in ESRD that rely pri-
marily on medical comorbidities [16]. In the current
study, we found that NH utilization was more strongly
Table 3 Crude and multivariable adjusted odds ratios (95% confidence intervals) for sensitivity and specificity of
CMS-2728 nursing home indicator among incident dialysis patients ≥ 75 years






75 – 79 1.00 1.00 1.00 1.00
80 – 84 1.01 (0.90, 1.13) 1.08 (0.92, 1.26) 0.81 (0.68, 0.96) 0.80 (0.64, 1.01)
85 – 89 0.98 (0.86, 1.12) 1.04 (0.86, 1.25) 0.71 (0.57, 0.88) 0.77 (0.58, 1.02)
≥90 1.24 (1.01, 1.51) 1.22 (0.92, 1.62) 0.86 (0.55, 1.34) 0.81 (0.48, 1.38)
Women (vs. men) 1.18 (1.08, 1.30) 1.07 (0.94, 1.23) 0.76 (0.65, 0.88) 1.06 (0.86, 1.31)
Hispanic or Latino (vs. non-Hispanic) 1.01 (0.83, 1.24) 0.90 (0.67, 1.21) 1.42 (1.05, 1.92) 2.01 (1.31, 3.06)
Race
White 1.00 1.00 1.00 1.00
Black/African American 1.44 (1.28, 1.63) 1.08 (0.90, 1.30) 0.85 (0.70, 1.04) 1.29 (0.97, 1.72)
American Indian/Alaska 0.28 (0.09, 0.94) 0.16 (0.03, 0.81) 1.14 (0.28, 4.67) 1.40 (0.18, 10.90)
Native Asian 0.79 (0.56, 1.11) 1.27 (0.80, 2.03) 1.12 (0.71, 1.79) 1.17 (0.66, 2.07)
Other* 1.08 (0.54, 2.17) 0.80 (0.29, 2.21) 3.02 (0.75, 12.2) –
Medicaid (vs. no Medicaid) 1.91 (1.70, 2.13) 1.88 (1.59, 2.22) 0.57 (0.47, 0.69) 0.76 (0.58, 0.99)
Region of residence
Northeast 1.16 (0.98, 1.36) 1.12 (0.89, 1.40) 0.58 (0.45, 0.76) 0.72 (0.52, 1.00)
South 1.87 (1.60, 2.18) 1.55 (1.24, 1.94) 0.71 (0.56, 0.90) 1.07 (0.78, 1.46)
Midwest 1.90 (1.63, 2.23) 1.96 (1.56, 2.46) 0.62 (0.48, 0.80) 0.88 (0.63, 1.24)
West 1.00 1.00 1.00 1.00
Primary cause of ESRD (diabetes vs. other) 1.15 (1.04, 1.26) 1.16 (1.00, 1.33) 0.81 (0.69, 0.94) 0.81 (0.65, 1.01)
CVD Comorbidity (vs. no CVD comorbidity)
Congestive heart failure 1.04 (0.84, 1.14) 0.89 (0.77, 1.02) 0.61 (0.52, 0.72) 0.99 (0.80, 1.23)
Atherosclerotic heart disease 0.90 (0.81, 0.99) 0.88 (0.76, 1.03) 0.89 (0.75, 1.04) 1.25 (0.99, 1.58)
Cerebrovascular disease 1.45 (1.28, 1.65) 1.14 (0.96, 1.36) 0.45 (0.37, 0.54) 0.75 (0.58, 0.96)
Peripheral vascular disease 1.06 (0.94, 1.19) 0.87 (0.73, 1.03) 0.60 (0.50, 0.71) 0.69 (0.55, 0.88)
Other 1.41 (1.27, 1.57) 1.15 (0.99, 1.33) 0.50 (0.42, 0.59) 0.80 (0.64, 0.99)
Functional impairment (vs. no functional impairment)** 11.21 (10.02, 12.53) 10.42 (9.10, 11.93) 0.06 (0.05, 0.08) 0.09 (0.07, 0.11)
Serum albumin (per 1 g/dL) 0.87 (0.80, 0.94) 0.96 (0.86, 1.07) 2.66 (2.34, 3.02) 1.80 (1.54, 2.10)
Serum creatinine (per 1 mg/dL) 0.98 (0.96, 1.00) 1.00 (0.97, 1.02) 1.13 (1.08, 1.17) 1.07 (1.01, 1.12)
Hemoglobin (per 1 g/dL) 0.99 (0.96, 1.03) 1.00 (0.96, 1.05) 1.14 (1.08, 1.20) 1.01 (0.94, 1.08)
Dialysis facility/Center (vs. SNF)*** 0.28 (0.21, 0.38) 0.51 (0.33, 0.81) – –
Predialysis nephrology care (vs. No care) 0.83 (0.75, 0.92) 0.86 (0.75, 1.00) 3.19 (2.67, 3.82) 2.04 (1.62, 2.57)
Arteriorvenous fistula (vs. Graft) 0.68 (0.47, 0.96) 0.80 (0.50, 1.28) 2.61 (1.43, 4.77) 1.83 (0.90, 3.76)
CVD = cardiovascular disease, SNF = skilled nursing facility.
*unstable estimates due to very small numbers in the other race category includes one of more of inability to ambulate.
**inability to ambulate, transfer, or needs assistance with daily activities.
***unstable estimates due to very small numbers receiving dialysis in SNF.
Multivariable adjustment includes age, sex, ethnicity, race, Medicaid coverage, region of residence, primary cause of dialysis, CVD comorbidity, functional
impairment, serum albumin, serum creatinine, hemoglobin, primary dialysis setting, predialysis nephrology care, initial type of dialysis access and incident
ESRD year.
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items included in our model and the magnitude of this as-
sociation was on the order of a ten year increase in age.
Indices that take into account not just comorbidities, butcontextual factors such as markers of frailty, the need for
NH care, or healthcare intensity at the time of dialysis ini-
tiation may have the potential to improve prognostication
[17,18].





















Time (months) 0 6 12 24 36 48 60 72
MDS/2728 2,565 1,268 868 511 295 193 118 70
MDS/2728 No 5,236 2,830 2,115 1,319 847 540 356 241
No MDS/2728 656 343 233 131 72 42 30 21
No MDS/No 2728 19,456 14,894 12,410 9,033 6,582 4,672 3,224 2,260
Number of deaths 
0 6 12 24 36 48 60 72
MDS/2728 0 1,211 1,611 1,968 2,184 2,286 2,361 2,409
MDS/2728 No 0 2,222 2,937 3,732 4,204 4,511 4,693 4,808
No MDS/2728 0 292 402 504 563 593 605 613
No MDS/No 2728 0 3,995 6,466 9,812 12,242 14,143 15,586 16,546
Figure 1 Survival curves (Kaplan-Meier method) for incident ESRD patients ≥ 75 years old by CMS-2728 and Minimum Data Set (MDS)
nursing home status agreement.
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the proportion of incident ESRD patients ≥ 75 years old
receiving NH care by two thirds. Similarly, a low sensi-
tivity for the identification of patient characteristics such
as smoking status or reported predialysis nephrology
care has been previously described [19-21]. These dis-
crepancies have been speculated to be due to nephrolo-
gists not having access to the context of the whole
patient as may occur during urgent dialysis initiation,
completion of the form by dialysis unit personnel who
may not be familiar with the patient’s full medical his-
tory or ambiguity in the CMS-2728 form itself [19,22].
Along these lines, there are several potential explana-
tions for the low sensitivity of the CMS-2728 NH status.
First, providers completing the CMS-2728 may not be
aware if the patient is currently receiving NH care or
may not believe that this is important information to ac-
curately report. The patient may not have been asked or
in the case of delirium or critical illness the patient
might not be able to say. Additionally, providers may
not be familiar with language used on CMS-2728 or thetime frame over which to consider NH status. The term
“institutionalized” may be interpreted as requiring long
term care rather than post-acute care in a skilled nursing
facility care that is covered by Medicare Part A after a
qualifying hospital stay. This may be supported by our
finding of a higher average number of NH days among
those identified by the CMS-2728 compared to those
not identified as receiving NH care. Differences between
assisted living, NH and other institution may not be
clear especially as patients may be transitioning from
one level of care to another, [23] however including
assisted living and other institution in a secondary ana-
lysis only resulted in a small increase in the sensitivity.
Lastly, because of the number of transitions between
care sites near the time of dialysis initiation, patients
may have recently transitioned out of or into a NH. In
this case, the provider may be aware of the patient’s NH
status, but neither the CMS-2728, nor the MDS, may
provide the granularity necessary to determine if a pa-
tient was in a NH on the exact ESRD date. One ap-
proach to improving the performance of the CMS-2728
Table 4 Crude and multivariable adjusted hazards ratios
(95% confidence intervals) for mortality among incident
dialysis patients ≥ 75 years old (n = 27,913)
Crude Multivariable
adjusted
NH Status – by MDS*
No MDS (n = 20,112) 1 (ref) 1 (ref)




NH Status – by CMS-2728 **
No 2728 (n = 24,692) 1 (ref) 1 (ref)





MDS/2728 2.08 (1.99, 2.17) 1.55 (1.46, 1.64)
MDS/No 2728 1.75 (1.69, 1.81) 1.48 (1.42, 1.54)
No MDS/2728 1.97 (1.82, 2.13) 1.38 (1.25, 1.52)
No MDS/No 2728 1 (ref) 1(ref)
Age, years
75 – 79 1 (ref) 1 (ref)
80 – 84 1.23 (1.19, 1.26) 1.17 (1.13, 1.21)
85 – 89 1.51 (1.46, 1.57) 1.40 (1.34, 1.46)
≥90 1.93 (1.81, 2.06) 1.69 (1.57, 1.82)
Women 0.96 (0.93, 0.98) 0.87 (0.85, 0.90)
Hispanic or Latino 0.85 (0.81, 0.89) 0.75 (0.70, 0.79)
Race
White 1 (ref) 1 (ref)
Black or African American 0.79 (0.76, 0.81) 0.77 (0.74, 0.81)
American Indian/Alaska Native 0.82 (0.67, 1.02) 0.89 (0.70, 1.14)
Asian 0.71 (0.66, 0.77) 0.77 (0.70, 0.84)
Other 0.72 (0.62, 0.83) 0.65 (0.53, 0.79)
Medicaid 1.01 (0.97, 1.04) 1.03 (0.99, 1.08)
Region of residence
Northeast 1.10 (1.06, 1.14) 0.97 (0.92, 1.01)
South 1.15 (1.11, 1.19) 1.09 (1.04, 1.14)
Midwest 1.11 (1.07, 1.15) 0.95 (0.90, 0.99)
West 1 (ref) 1 (ref)
Primary cause of ESRD
(diabetes vs. other)
1.01 (0.98, 1.03) 1.02 (0.99, 1.06)
CVD Comorbidity
Congestive heart failure 1.37 (1.34, 1.41) 1.18 (1.14, 1.22)
Atherosclerotic heart disease 1.16 (1.13, 1.19) 1.03 (0.99, 1.06)
Cerebrovascular disease 1.22 (1.17, 1.26) 1.06 (1.01, 1.11)
Peripheral vascular disease 1.21 (1.17, 1.24) 1.08 (1.03, 1.12)
Other 1.26 (1.22, 1.29) 1.09 (1.06, 1.13)
Functional impairment† 1.60 (1.55, 1.65) 1.25 (1.20, 1.31)
Serum albumin (g/dL) 0.75 (0.73, 0.76) 0.85 (0.83, 0.87)
Serum creatinine (mg/dL) 0.95 (0.95, 0.96) 0.97 (0.96, 0.97)
Table 4 Crude and multivariable adjusted hazards ratios
(95% confidence intervals) for mortality among incident
dialysis patients ≥ 75 years old (n = 27,913) (Continued)
Hemoglobin (g/dL) 0.97 (0.97, 0.98) 0.99 (0.98, 1.00)
Dialysis facility/Center (vs. SNF) 0.65 (0.57, 0.74) 1.17 (0.99, 1.38)
Predialysis nephrology care (vs. No
care)
0.74 (0.72, 0.76) 0.90 (0.87, 0.94)
Arteriorvenous fistula (vs. Graft) 0.92 (0.86, 0.99) 0.91 (0.84, 0.99)
CVD = cardiovascular disease, SNF = skilled nursing facility.
†includes one of more of inability to ambulate, inability to transfer, or needs
assistance with daily activities.
*Model 1 – NH status defined by MDS alone.
**Model 2 – NH status defined by CMS-2728 alone.
***Model 3 – NH status defined by MDS/2728 agreement category.
For each model multivariable adjustment includes age, sex, ethnicity, race,
Medicaid coverage, region of residence, primary cause of dialysis, CVD
comorbidity, functional impairment, serum albumin, serum creatinine,
hemoglobin, primary dialysis setting, predialysis nephrology care, initial type
of dialysis access and incident ESRD year.
Bowling et al. BMC Nephrology  (2015) 16:32 Page 8 of 10to identify patients receiving NH and other markers of
frailty is to remove these from the comorbidities section
(item 17) and creating a separate section on frailty, func-
tion and nursing home care using standardized and pre-
viously validated assessments.
Despite the low sensitivity, 80% of those identified by
the CMS-2728 had MDS data indicating that they were
receiving NH care at the time of dialysis initiation. These
findings have important research implications. For out-
comes research purposes where the aim is to create a
cohort with a known condition using CMS data such as
the CMS-2728, having a high PPV is important to en-
sure the majority of patients have the condition of inter-
est [24]. Using Medicare claims alone to develop an
analytic cohort of patients receiving NH care can be
quite challenging [25]. In fact, compared to previous
studies using complex Medicare claims algorithms to
identify patients receiving NH care, we found a similar
PPV using only the single Item 17u on the CMS-2728
[13]. Additionally, we found a similarly high NPV. Hav-
ing both a high PPV and NPV has been described as be-
ing important for comparing those with versus without a
certain condition. Our findings support the use of the
CMS-2728 NH indicator to define NH status as has
been recently used in a sub-group analysis of dialysis
timing and outcomes in older adults [26]. In the current
study, we identified cross sectional associations between
NH status and functional impairment and a prospective
association with mortality risk that was robust to multi-
variable adjustment for several mortality risk factors
corresponding to a high predictive validity of the CMS-
2728 NH item.
Educational resources exist to identify and address is-
sues related to overall health status such as frailty and
functional decline in order to improve outcomes [27,28].
Bowling et al. BMC Nephrology  (2015) 16:32 Page 9 of 10However, currently there are no specific recommenda-
tions for older ESRD patients requiring NH care. Find-
ings from the current study suggest possible gaps in the
coordination of care between dialysis units and nursing
facilities and an opportunity to improve recognition and
reporting of NH care among incident ESRD patients ≥
75 years of age. In addition, despite a considerably lower
proportion of reported functional impairment among
those missed by the CMS-2728, mortality risk was simi-
lar to those identified by both the MDS and CMS-2728
as receiving NH care. Future studies may be necessary
to determine whether or not NH care itself contributes
to the poor outcomes in this group or is merely a
marker of disease burden and declining health status.
Regardless, recognizing the mortality risk associated
with the need for NH care, even among patients without
reported functional impairment, may provide important
information to support clinical decision making and
communication with patients about advance care
planning.
Potential limitations include the reliance on data
from the CMS-2728 to identify patient demographic,
medical and treatment characteristics. Prior studies
have shown substantial disagreement between the
CMS-2728 and Medicare claims for certain items in-
cluding predialysis nephrology care [15,16]. Addition-
ally, lack of instructions or clarification on the NH
item with regards to terminology (i.e., institutionalized,
assisted living, NH, other institution) may lead to mis-
classification. Institutionalization is listed under co-
morbid conditions and the instructions state to “check all
that apply currently and/or during the last 10 years” how-
ever, MDS data was not available 10 years prior to dialysis
initiation in the current analysis. Although the MDS has
been used previously as the “gold standard” for NH care,
accuracy has not been reported and is limited only to
Medicare or Medicaid certified NHs nor does it include
patients living at home who may be receiving equal levels
of care through Home Health agencies or paid and infor-
mal caregivers. Despite these limitations the large sample
size, high PPV, NPV and predictive validity of the CMS-
2728 should be considered strengths.
Conclusion
In conclusion, among incident ESRD patients ≥ 75 years
the Medical Evidence Report CMS-2728 NH item identi-
fied older adults with functional impairment and increased
risk for mortality, however the CMS-2728 may underesti-
mate the burden of NH care by nearly two thirds. Future
studies should determine if interventions targeting older
adults requiring NH care can improve outcomes, improve
care coordination between NHs and dialysis facilities, or
support communication with patients about advance care
planning.Additional file
Additional file 1: Accuracy of CMS-2728 using other nursing home
definitions. Outline of the FPAQ questionnaire.
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